![Cécile Chartier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cécile Chartier
Direktor/Vorstandsmitglied bei
CELLECTIS S.A.
Profil
Cécile Chartier currently works at Cellectis SA, as Director from 2023 and NextVivo, Inc., as Chief Scientific Officer.
Dr. Chartier also formerly worked at Mereo BioPharma 5, Inc., as Senior Director-Target Validation and Iovance Biotherapeutics, Inc., as Vice President-Research from 2017 to 2021.
Dr. Chartier received her doctorate degree from Universite Louis Pasteur Strasbourg I.
Aktive Positionen von Cécile Chartier
| Unternehmen | Position | Beginn |
|---|---|---|
| CELLECTIS S.A. | Direktor/Vorstandsmitglied | 27.06.2023 |
NextVivo, Inc.
 NextVivo, Inc. Packaged SoftwareTechnology Services Develops organoid technology platform for drug development services | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Cécile Chartier
| Unternehmen | Position | Ende |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2021 |
| ONCOMED PHARMACEUTICALS INC | Corporate Officer/Principal | - |
Ausbildung von Cécile Chartier
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
17
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Mereo BioPharma 5, Inc.
 Mereo BioPharma 5, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer stem cell therapeutics | Health Technology |
Cellectis SA
 Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
Iovance Biotherapeutics, Inc.
 Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
NextVivo, Inc.
NextVivo, Inc. Packaged SoftwareTechnology Services Develops organoid technology platform for drug development services | Technology Services |
Universite Louis Pasteur Strasbourg I
 Universite Louis Pasteur Strasbourg I Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
